Amended Statement of Ownership (sc 13g/a)
February 23 2017 - 5:26PM
Edgar (US Regulatory)
|
UNITED
STATES
|
|
SECURITIES
AND EXCHANGE COMMISSION
|
|
Washington,
D.C. 20549
|
|
|
|
SCHEDULE
13G
|
|
|
|
Under
the Securities Exchange Act of 1934
|
|
Amendment
No. 2
|
|
|
|
Intec
Pharma Ltd.
|
|
(Name
of Issuer)
|
|
|
|
Common
Stock, $0.01 par value
|
|
(Title
of Class of Securities)
|
|
|
|
523251106
|
|
(CUSIP
Number)
|
|
|
|
Opaleye
Management Inc., One Boston Place, Suite 2600, Boston, MA 02108, 617-229-5085
|
|
(Name,
Address and Telephone Number of Person
Authorized
to Receive Notices and Communications)
|
|
|
|
December
31, 2016
|
|
(Date
of Event which Requires Filing of this Statement)
|
Check the appropriate box to designate the rule pursuant
to which this Schedule is filed:
* The remainder of this cover page shall be filled out for
a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment
containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act")
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
|
CUSIP No. 523251106
|
13G
|
Page 2 of 6 Pages
|
|
1.
|
Names of Reporting Persons.
|
|
|
Opaleye Management Inc.
|
|
|
I.R.S. Identification Nos. of above persons (entities only)
20-5648796
|
|
|
|
|
2.
|
Check the Appropriate Box If a Member of a Group (See Instructions)
|
|
|
(a)
¨
|
|
|
(b)
¨
|
|
3.
|
SEC Use Only
|
|
|
|
|
|
|
|
4.
|
Citizenship or Place of Organization
|
|
|
|
|
|
Opaleye Management Inc.
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON WITH
|
5.
|
SOLE VOTING POWER
|
|
|
|
|
|
0 shares
|
|
6.
|
SHARED VOTING POWER
|
|
|
|
|
|
0 shares
|
|
7.
|
SOLE DISPOSITIVE POWER
|
|
|
|
|
|
0 shares
|
|
8.
|
SHARED DISPOSITIVE POWER
|
|
|
|
|
|
0 shares
|
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
|
|
|
|
|
|
Opaleye Management Inc. — 0 shares
|
|
10.
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions)
¨
|
|
|
|
|
11.
|
Percent of Class Represented by Amount in Row (9)
|
|
|
|
|
|
Opaleye Management Inc. — 0%
|
|
12.
|
Type of Reporting Person (See Instructions)
|
|
|
|
|
|
Opaleye Management Inc. — 00 (Limited Liability Company)
|
|
CUSIP No. 523251106
|
13G
|
Page 3 of 6 Pages
|
|
1.
|
Names of Reporting Persons.
|
|
|
James Silverman
|
|
|
I.R.S. Identification Nos. of above persons (entities only)
N/A
|
|
|
|
|
2.
|
Check the Appropriate Box If a Member of a Group (See Instructions)
|
|
|
(a)
¨
|
|
|
(b)
¨
|
|
3.
|
SEC Use Only
|
|
|
|
|
|
|
|
4.
|
Citizenship or Place of Organization
|
|
|
|
|
|
James Silverman — United States
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON WITH
|
5.
|
SOLE VOTING POWER
|
|
|
|
|
|
0 shares
|
|
6.
|
SHARED VOTING POWER
|
|
|
|
|
|
0 shares
|
|
7.
|
SOLE DISPOSITIVE POWER
|
|
|
|
|
|
0 shares
|
|
8.
|
SHARED DISPOSITIVE POWER
|
|
|
|
|
|
0 shares
|
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
|
|
|
|
|
|
James Silverman — 0 shares
|
|
10.
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions)
¨
|
|
|
|
|
11.
|
Percent of Class Represented by Amount in Row (9)
|
|
|
|
|
|
James Silverman — 0%
|
|
12.
|
Type of Reporting Person (See Instructions)
|
|
|
|
|
|
James Silverman — IN
|
|
CUSIP No. 523251106
|
13G
|
Page 4 of 6 Pages
|
Item 1.
|
|
(a)
|
Name of Issuer:
Intec Pharma Ltd.
|
|
|
(b)
|
Address of Issuer's Principal Executive Offices:
|
12 Hartom Street
Har Hotzvim
Jerusalem L3 777512
Item 2.
|
|
(a)
|
Name of Person Filing:
Opaleye Management Inc.
|
James Silverman
|
|
(b)
|
Address of the Principal Office or, if none, residence:
Opaleye Management Inc.
|
James Silverman
One Boston Place
Suite 2600
Boston, MA 02108
Opaleye Management Inc. — Massachusetts
James
Silverman — United States
|
|
(d)
|
Title of Class of Securities:
|
Common Stock, $0.01 par value
|
|
(e)
|
CUSIP Number: 523251106
|
Item 3. If this statement is filed pursuant to SS.240.13d-1(b)
or 240.13d-2(b) or (c), check whether the person filing is a:
|
|
(a)
|
¨
|
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
|
|
|
|
|
|
|
|
(b)
|
¨
|
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
|
|
|
|
|
|
|
|
(c)
|
¨
|
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
|
|
|
|
|
|
|
|
(d)
|
¨
|
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).
|
|
|
|
|
|
|
|
(e)
|
¨
|
An investment adviser in accordance with S.240.13d-1(b)(1)(ii)(E);
|
|
|
|
|
|
|
|
(f)
|
¨
|
An employee benefit plan or endowment fund in accordance with S.240.13d-1(b)(1)(ii)(F);
|
|
|
|
|
|
|
|
(g)
|
¨
|
A parent holding company or control person in accordance with S. 240.13d-1(b)(1)(ii)(G);
|
|
|
|
|
|
|
|
(h)
|
¨
|
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
|
|
|
|
|
|
|
(i)
|
¨
|
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
|
|
|
|
|
|
|
|
(j)
|
¨
|
Group, in accordance with S.240.13d-1(b)(1)(ii)(J).
|
|
CUSIP No. 523251106
|
13G
|
Page 5 of 6 Pages
|
Item 4. Ownership
Provide the following information regarding the aggregate
number and percentage of the class of securities of the issuer identified in Item 1.
|
|
(a)
|
Amount beneficially owned: Opaleye Management Inc. —
0 shares
|
James Silverman — 0 shares
|
|
(b)
|
Percent of class: Opaleye Management Inc. — 0%
|
James Silverman — 0%
|
|
(c)
|
Number of shares as to which the person has:
|
|
|
(i)
|
Sole power to vote or to direct the vote:
Opaleye Management Inc. — 0 shares
|
James Silverman — 0 shares
|
|
(ii)
|
Shared power to vote or to direct the vote:
Opaleye Management Inc. — 0 shares
|
James Silverman — 0 shares
|
|
(iii)
|
Sole power to dispose or to direct the disposition of:
|
Opaleye Management Inc. — 0 shares
James Silverman
— 0 shares
|
|
(iv)
|
Shared power to dispose or to direct the disposition of:
|
Opaleye Management Inc. — 0 shares
James Silverman — 0 shares
Item 5. Ownership of Five Percent or Less of a Class.
If
this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities, check the following
x
.
Item 6. Ownership of More than Five Percent on Behalf
of Another Person.
Item 7. Identification and Classification of the Subsidiary
Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
Item 8. Identification and Classification of Members
of the Group
Item 9. Notice of Dissolution of Group
Item 10. Certification
By signing below I certify that, to the best of my
knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect
of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with
or as a participant in any transaction having that purpose or effect.
After reasonable inquiry and to the best of my knowledge
and belief, I certify that the information set forth in this statement is true, complete and correct.
|
Dated: 02/23/2017
|
OPALEYE MANAGEMENT INC.
|
|
|
By: /s/ James Silverman
James Silverman, President
|
|
|
|
|
|
JAMES SILVERMAN
|
|
|
By: /s/ James Silverman
|
|
|
James Silverman, individually
|
|
CUSIP No. 523251106
|
13G
|
Page 6 of 6 Pages
|
JOINT FILING AGREEMENT
This Joint Filing Agreement, dated April 21, 2016, is
entered into by and between Opaleye Management Inc., a Massachusetts corporation, and James Silverman, an individual
(collectively referred to herein as (the "Filers") Each of the Filers may be required to file with the U.S.
Securities and Exchange Commission a statement on Schedule 13G with respect to common stock, no par value, of Intec Pharma
Ltd. beneficially owned by them from time to time. Pursuant to and in accordance with Rule 13(d)(1)(k) promulgated under the
Securities Exchange Act of 1934, as amended, the Filers hereby agree to file a single statement on Schedule 13G and/or 13D
(and any amendments thereto) on behalf of each of such parties, and hereby further agree to file this Joint Filing Agreement
as an exhibit to such statement, as required by such rule. This Joint Filing Agreement may be terminated by any of the Filers
upon one week's prior written notice or such lesser period of notice as the Filers may mutually agree.
Executed and delivered as of the date first above written.
|
Dated: 02/23/2017
|
OPALEYE MANAGEMENT INC.
|
|
|
|
|
|
By: /s/ James Silverman
James Silverman
President
|
|
|
|
|
|
JAMES SILVERMAN
|
|
|
|
|
|
By: /s/ James Silverman
|
|
|
James Silverman, individually
|
Intec Parent (NASDAQ:NTEC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Intec Parent (NASDAQ:NTEC)
Historical Stock Chart
From Apr 2023 to Apr 2024
